Meeting
2014 ASCO Annual Meeting
Multicenter observational study of reactivation of hepatitis B virus (HBV) caused by chemotherapy for solid tumors (ST).
Authors
Shunsuke Kondo
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
Shunsuke Kondo , Masafumi Ikeda , Masatoshi Kudo , Seijin Nadano , Junji Furuse , Yukio Osaki , Takashi Kumada , Kazuyoshi Ohkawa , Masashi Mizokami
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Epidemiology
Clinical Trial Registration Number
UMIN000005369
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1590)
DOI
10.1200/jco.2014.32.15_suppl.1590
Abstract #
1590
Poster Bd #
372
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Quality Care Symposium
Hepatitis B reactivation in patients with solid tumors: A systematic review and meta-analysis.
First Author: Lisa K. Hicks
Poster
2014 Gastrointestinal Cancers Symposium
Observational study of the first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial.
First Author: Kei Muro
Poster
2024 ASCO Annual Meeting
The safety and efficacy of ivonescimab in combination with chemotherapy as first-line treatment for advanced biliary tract cancer.
First Author: Jieer Ying
Poster
2023 ASCO Annual Meeting
Phase II results of ivonescimab (AK112/ SMT112), a novel PD-1/VEGF bispecific, in combination with chemotherapy for first line treatment of advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations (AGA) in EGFR/ALK.
First Author: Li Zhang